How the Pandemic Impacted Prostate Cancer Diagnostics
A senior medical director for Quest Diagnostics discusses how the pandemic impacted prostate cancer diagnostics and how it will impact clinical labs.
Read MorePosted by Chris Wolski | Jan 14, 2022 | Prostate |
A senior medical director for Quest Diagnostics discusses how the pandemic impacted prostate cancer diagnostics and how it will impact clinical labs.
Read MorePosted by Andy Lundin | Jan 10, 2022 | Lung Cancer |
A blood test in tandem with reviewing an individual’s smoking history can more accurately determine if they may benefit from lung cancer screening.
Read MorePosted by Andy Lundin | Jan 6, 2022 | Prostate, Rapid Assays |
A portable and rapid prostate cancer screening kit could provide early warning to populations with higher incidence of prostate cancer.
Read MorePosted by Andy Lundin | Dec 27, 2021 | Prostate |
A new study has identified novel cancer markers in patients with aggressive prostate cancer that indicate poorer survival.
Read MorePosted by Chris Wolski | Dec 9, 2021 | Diagnostic Technologies |
Industry experts predict a year of change and transformation ahead as the COVID-19 pandemic continues to influence the way clinical labs operate.
Read More